Ueckermann V, Hoosien E, De Villiers N, Geldenhuys J
Department Internal Medicine, University of Pretoria, Pretoria, South Africa.
Department of Clinical Microbiology, Ampath National Reference Laboratory, Centurion, South Africa.
Case Rep Infect Dis. 2020 Feb 12;2020:8462659. doi: 10.1155/2020/8462659. eCollection 2020.
Dysbiosis of the microbiome is a common finding in critically ill patients, who receive broad-spectrum antibiotics and various forms of organ support. Multidrug-resistant (MDR) organisms are a growing threat in all areas of medicine, but most markedly in the critically ill, where there is both loss of host defences and widespread use of broad spectrum antibiotics. We present a case of a critically ill patient with persistent MDR infection, successfully treated with fecal microbiota transplantation (FMT), using stool of a rigorously-screened, healthy donor. FMT for colitis has been well described in the literature and is an established therapy for recurrent infections with . The use of FMT for other multidrug-resistant organisms is less frequently described, particularly in the context of critically ill patients. In our case, we have culture-documented clearance of the MDR form a patient of FMT.
微生物群失调在接受广谱抗生素和各种形式器官支持的重症患者中很常见。多重耐药(MDR)微生物在医学的各个领域构成的威胁日益增加,但在重症患者中最为明显,因为这些患者既存在宿主防御功能丧失,又广泛使用广谱抗生素。我们报告一例重症患者持续存在MDR感染,使用经过严格筛选的健康供体的粪便进行粪便微生物群移植(FMT)成功治愈。FMT治疗结肠炎在文献中已有充分描述,是复发性感染的既定疗法。FMT用于其他多重耐药微生物的情况较少被描述,尤其是在重症患者中。在我们的病例中,我们通过培养证明FMT使患者体内的MDR清除。